• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Hematocrit Test Companies

    ID: MRFR/LS/4105-HCR
    110 Pages
    Rahul Gotadki
    October 2025

    The hematocrit test is a blood test that measures the percentage of red blood cells in a person's blood. This test provides valuable information about the composition of blood and is often used to diagnose and monitor conditions such as anemia and polycythemia. Several companies are involved in the production of hematocrit testing equipment and related products.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Hematocrit Test Market Research Report- Forecast till 2032 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Hematocrit Test Market

    Hematocrit Test Key CompaniesLatest hematocrit test Companies Update

    Nov 2023: A new collaboration to enhance automation options for single-cell assay workflows was announced by 10x Genomics, Inc., a leader in single-cell and spatial biology, and Beckman Coulter Life Sciences, a leader in laboratory automation and innovation worldwide. As per the agreement, Beckman Coulter Life Sciences will use 10x Genomics' specialized Chromium Single Cell kits on its Biomek i7 Automated Liquid Handler. With the help of this specially designed program, 10x Genomics single-cell library preparation will be automated on a large scale and at high quality, producing finished libraries that are prepared for sequencing. In oncology, immunology, neurology, and other fields, single-cell techniques are increasingly used to help scientists understand the complexity of biology and advance novel scientific findings. Higher-level research requires more comprehensive solutions; therefore, automation of manual processes such as library preparation enables greater throughput.


    Nov 2023: Hepatitis B e antigen (HBeAg) can be detected in human serum and plasma qualitatively and quantitatively with the new immunoassay Elecsys® HBeAg quant, which Roche recently introduced. With this launch, patients will receive confirmation of their hepatitis B (HBV) status, the degree of their infection, and treatment monitoring using a single test when paired with additional laboratory findings and clinical data. It is intended for use on cobas® e analyzers in nations that recognize the CE Mark. The new Elecsys HBeAg quant test will supplement existing HBV testing markers. Clinicians can ascertain the patient's illness phase and evaluate the virus's activity when a patient with suspected HBV returns a positive result for HBeAg.


    List of hematocrit test Key companies in the market

    • Abbott (U.S.)

    • F. Hoffmann-La Roche Ltd (Switzerland)

    • Siemens AG (Germany)

    • Beckman Coulter, Inc. (U.S.)

    • Bio-Rad Laboratories, Inc. (U.S.)

    • Horiba, Ltd. (Japan)

    • Mindray Medical International Limited (China)

    • Boule Diagnostics AB (Sweden)

    • Nihon Kohden Corporation (Japan)

    • Sysmex Corporation (Japan)